Weekly shot tested to shield diabetic hearts and kidneys
NCT ID NCT02251431
Summary
This study tested whether a weekly injection of the diabetes medication exenatide could help protect the heart and kidneys in people with type 2 diabetes who were at risk for heart problems and had mildly reduced kidney function. For 38 weeks, some participants received the real injection while others received a placebo (dummy shot), and researchers measured changes in specific blood and urine tests related to heart and kidney injury. The goal was to see if this treatment could slow down or prevent damage to these organs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Scott and White Research Institute- Baylor Heart and Vascular Hospital
Dallas, Texas, 75226, United States
Conditions
Explore the condition pages connected to this study.